Samalin Investment Counsel’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Sell
468
-29
-6% -$16.7K 0.07% 280
2026
Q1
$339K Sell
497
-6
-1% -$4.15K 0.12% 229
2025
Q4
$287K Sell
503
-26
-5% -$15.1K 0.1% 240
2025
Q3
$323K Sell
529
-27
-5% -$15.3K 0.11% 234
2025
Q2
$278K Buy
556
+7
+1% +$3.44K 0.11% 260
2025
Q1
$281K Buy
549
+30
+6% +$14.3K 0.11% 255
2024
Q4
$244K Hold
519
0.1% 247
2024
Q3
$274K Sell
519
-103
-17% -$50.4K 0.12% 234
2024
Q2
$271K Buy
622
+30
+5% +$13.7K 0.13% 230
2024
Q1
$283K Sell
592
-172
-23% -$79.2K 0.13% 224
2023
Q4
$358K Buy
764
+11
+1% +$5.16K 0.18% 192
2023
Q3
$332K Sell
753
-27
-3% -$11.9K 0.19% 163
2023
Q2
$356K Buy
780
+221
+40% +$100K 0.19% 149
2023
Q1
$258K Buy
559
+153
+38% +$71K 0.16% 187
2022
Q4
$222K Buy
+406
New +$212K 0.14% 206
2020
Q1
Sell
-12
Closed -$4K 396
2019
Q4
$4K Buy
+12
New +$4.22K ﹤0.01% 480

Other funds holding NOC

Samalin Investment Counsel's NOC Position: Q2 2026 in Review

Samalin Investment Counsel reduced its Northrop Grumman (NOC) stake by 5.8% in Q2 2026, selling an estimated $16.7K and leaving 468 shares worth $238K. The position accounts for 0.07% of the portfolio, ranked #280.

Samalin Investment Counsel first reported a position in NOC in Q4 2019 and has held it in 16 quarters since. The position peaked at $358K in Q4 2023. 863 funds tracked by Wall St. Rank hold NOC as of Q2 2026.

  • Samalin Investment Counsel held 468 shares of Northrop Grumman worth $238K as of Q2 2026.
  • Samalin Investment Counsel sold 29 Northrop Grumman shares in Q2 2026, an estimated $16.7K.
  • Northrop Grumman made up 0.07% of Samalin Investment Counsel's portfolio in Q2 2026, its #280 holding.
  • Samalin Investment Counsel first reported a position in Northrop Grumman in Q4 2019 and has held it in 16 quarters since.
  • Samalin Investment Counsel's Northrop Grumman position peaked at $358K in Q4 2023.
  • 863 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2026.

Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.